메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 25, Issue 27, 2007, Pages 4322-4324
Primary CNS lymphomas prognosis [8]
Author keywords

[No Author keywords available]
Indexed keywords

LACTATE DEHYDROGENASE;
EID: 34948858443     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.12.1285     Document Type: Letter
Times cited : (8)
References (8)
  • 1
    • 34247342137 scopus 로고    scopus 로고
    • Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model
    • Abrey LE, Ben-Porat L, Panageas KS, et al: Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model. J Clin Oncol 24:5711-5715, 2006
    • (2006) J Clin Oncol , vol.24 , pp. 5711-5715
    • Abrey, L.E.1    Ben-Porat, L.2    Panageas, K.S.3
  • 2
    • 0024514348 scopus 로고
    • Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma
    • Pollack IF, Dade Lunsford L, Flickinger JC, et al: Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63:939-947, 1989
    • (1989) Cancer , vol.63 , pp. 939-947
    • Pollack, I.F.1    Dade Lunsford, L.2    Flickinger, J.C.3
  • 3
    • 0037440231 scopus 로고    scopus 로고
    • Prognostic scoring system for primary CNS lymphomas: The International Extranodal Lymphoma Study Group experience
    • Ferreri AJM, Blay JY, Reni M, et al: Prognostic scoring system for primary CNS lymphomas: The International Extranodal Lymphoma Study Group experience. J Clin Oncol 21:266-272, 2003
    • (2003) J Clin Oncol , vol.21 , pp. 266-272
    • Ferreri, A.J.M.1    Blay, J.Y.2    Reni, M.3
  • 4
    • 0037188399 scopus 로고    scopus 로고
    • A multicenter study of treatment of primary CNS lymphoma
    • Ferreri AJM, Reni M, Pasini F, et al: A multicenter study of treatment of primary CNS lymphoma. Neurology 58:1513-1520, 2002
    • (2002) Neurology , vol.58 , pp. 1513-1520
    • Ferreri, A.J.M.1    Reni, M.2    Pasini, F.3
  • 5
    • 33646711027 scopus 로고    scopus 로고
    • MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas
    • Ferreri AJM, Dell'Oro S, Foppoli M, et al: MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas. Neurology 66:1435-1438, 2006
    • (2006) Neurology , vol.66 , pp. 1435-1438
    • Ferreri, A.J.M.1    Dell'Oro, S.2    Foppoli, M.3
  • 6
    • 0032412988 scopus 로고    scopus 로고
    • Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful?
    • Hayes DF, Track B, Harris AL: Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful? Breast Cancer Res Treat 52:305-319, 1998
    • (1998) Breast Cancer Res Treat , vol.52 , pp. 305-319
    • Hayes, D.F.1    Track, B.2    Harris, A.L.3
  • 7
    • 0031749549 scopus 로고    scopus 로고
    • Primary central nervous system lymphoma: Age and performance status are more important than treatment modality
    • Corry J, Smith JG, Wirth A, et al: Primary central nervous system lymphoma: Age and performance status are more important than treatment modality. Int J Radiat Oncol Biol Phys 41:615-620, 1998
    • (1998) Int J Radiat Oncol Biol Phys , vol.41 , pp. 615-620
    • Corry, J.1    Smith, J.G.2    Wirth, A.3
  • 8
    • 0027444652 scopus 로고
    • A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project
    • Anonymous
    • Anonymous: A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994, 1993
    • (1993) N Engl J Med , vol.329 , pp. 987-994

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.